LipoScience says it has processed more than one million NMR LipoProfile tests … a clinical tool that helps doctors better assess and treat cardiovascular disease (CVD) by directly measuring the number and size of lipoprotein particles in blood.

Lipoprotein particles, the containers that move cholesterol through the blood, have been proven to be a predictor of CVD risk versus standard cholesterol testing.

“This is a critical milestone for LipoScience that validates the utility and growing acceptance of the NMR LipoProfile test among physicians and their patients,” said Richard Brajer, president and chief executive officer of LipoScience. “With the NMR LipoProfile test, healthcare professionals have a superior tool to assess their patients’ risk of CVD and evaluate the effectiveness of therapy over time.”